{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:39:59Z","timestamp":1789540799319,"version":"build-2803163510"},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1016\/j.plefa.2004.03.007","type":"journal-article","created":{"date-parts":[[2004,5,29]],"date-time":"2004-05-29T06:54:22Z","timestamp":1085813662000},"page":"205-209","source":"Crossref","is-referenced-by-count":42,"title":["A pilot open case series of Ethyl-EPA supplementation in the treatment of anorexia nervosa"],"prefix":"10.1016","volume":"71","author":[{"given":"Agnes K","family":"Ayton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer","family":"Azaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F","family":"Horrobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.plefa.2004.03.007_BIB1","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1176\/appi.ajp.159.8.1284","article-title":"The outcome of anorexia nervosa in the 20th century","volume":"159","author":"Steinhausen","year":"2002","journal-title":"Am. J. Psychiatry"},{"issue":"9264","key":"10.1016\/j.plefa.2004.03.007_BIB2","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/S0140-6736(00)04406-8","article-title":"Outcome in patients with eating disorders","volume":"357","author":"Ben Tovim","year":"2001","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.plefa.2004.03.007_BIB3","first-page":"901","article-title":"Patients with anorexia nervosa demonstrate deficiencies of selected essential fatty acids, compensatory changes in nonessential fatty acids and decreased fluidity of plasma lipids","volume":"125","author":"Holman","year":"1995","journal-title":"J. Nutr."},{"issue":"5","key":"10.1016\/j.plefa.2004.03.007_BIB4","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/ajcn\/41.5.1054","article-title":"Vitamin E, vitamin A and essential fatty acid status of patients hospitalized for anorexia nervosa","volume":"41","author":"Langan","year":"1985","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.plefa.2004.03.007_BIB5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0753-3322(02)00253-6","article-title":"The importance of the ratio of omega-6\/omega-3 essential fatty acids","volume":"56","author":"Simopoulos","year":"2002","journal-title":"Biomed. Pharmacother."},{"issue":"10","key":"10.1016\/j.plefa.2004.03.007_BIB6","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archpsyc.59.10.913","article-title":"A dose ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs","volume":"59","author":"Peet","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"issue":"8","key":"10.1016\/j.plefa.2004.03.007_BIB7","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1742-1241.2001.tb11122.x","article-title":"Eicosapentaenoic acid in treatment-resistant depression associated with symptom remission, structural brain changes and reduced neuronal phospholipid turnover","volume":"55","author":"Puri","year":"2001","journal-title":"Int. J. Clin. Pract."},{"issue":"3","key":"10.1016\/j.plefa.2004.03.007_BIB8","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1176\/appi.ajp.159.3.477","article-title":"Addition of Omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder","volume":"159","author":"Nemets","year":"2002","journal-title":"Am. J. Psychiatry"},{"issue":"9","key":"10.1016\/j.plefa.2004.03.007_BIB9","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1176\/appi.ajp.159.9.1596","article-title":"Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia","volume":"159","author":"Emsley","year":"2002","journal-title":"Am. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.plefa.2004.03.007_BIB10","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1176\/appi.ajp.158.12.2071","article-title":"A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia","volume":"158","author":"Fenton","year":"2001","journal-title":"Am. J. Psychiatry"},{"issue":"1 Suppl","key":"10.1016\/j.plefa.2004.03.007_BIB11","doi-asserted-by":"crossref","first-page":"171S","DOI":"10.1093\/ajcn\/71.1.171S","article-title":"Importance of n-3 fatty acids in health and disease [see comments.] [Review] [38 refs]","volume":"71","author":"Connor","year":"2000","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.plefa.2004.03.007_BIB12","first-page":"385A","article-title":"Weight gain is associated with improved quality of life in patients with cancer cachexia consuming an energy and protein dense, high n-3 fatty acid oral supplement","volume":"21","author":"von Meyenfeldt","year":"2002","journal-title":"Proc. Am. Soc. Clin. Oncol."},{"issue":"1 Suppl","key":"10.1016\/j.plefa.2004.03.007_BIB13","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/0899-9007(96)90015-5","article-title":"Inhibition of lipolysis and muscle protein degradation by EPA in cancer cachexia","volume":"12","author":"Tisdale","year":"1996","journal-title":"Nutrition"},{"issue":"5","key":"10.1016\/j.plefa.2004.03.007_BIB14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1177\/0148607188012005521","article-title":"Linseed and cod liver oil induce rapid growth in a 7-years-old girl with n-3 fatty acid deficiency","volume":"12","author":"Bjerve","year":"1988","journal-title":"J. Parenter. Enter. Nutr."},{"issue":"1","key":"10.1016\/j.plefa.2004.03.007_BIB15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0031-3955(05)70292-3","article-title":"The role of polyunsaturated fatty acids in term and preterm infants and breastfeeding mothers [Review] [78 refs]","volume":"48","author":"Heird","year":"2001","journal-title":"Pediatr. Clin. North. Am."},{"issue":"10","key":"10.1016\/j.plefa.2004.03.007_BIB16","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archpsyc.59.10.913","article-title":"A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs","volume":"59","author":"Peet","year":"2002","journal-title":"Arch. Gen. Psychiatry"}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327804000584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327804000584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T14:37:06Z","timestamp":1705156626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952327804000584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0952327804000584"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2004.03.007","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}